Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature Communications (2)
Nature (2)
Nature Neuroscience (2)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (6)

Subject Check one or more subjects to show results from those subjects only.

Cell biology
Diseases
Immunology
Medical research
Microbiology
Neuroscience
Pathogenesis
Scientific community

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–6 of 6 results

Advanced filters: Author: Tom Aschman Clear advanced filters

Amplification of autoimmune organ damage by NKp46-activated ILC1s

NKp46⁺ innate lymphoid cells are identified as pivotal signal amplifiers of autoinflammatory responses in lupus nephritis.

Stylianos-Iason Biniaris-Georgallis
Tom Aschman
Antigoni Triantafyllopoulou
Research13 Aug 2024
Nature

Volume: 634, P: 952-960
Proteomic and transcriptomic profiling of brainstem, cerebellum and olfactory tissues in early- and late-phase COVID-19

Radke et al. found an interferon response in the brainstem nuclei of acute COVID-19 that, in addition to the inflammatory reaction, spreads throughout the vascular unit altering glial cells and resolves in late disease states in the absence of brain infection.

Josefine Radke
Jenny Meinhardt
Helena Radbruch
Research16 Feb 2024
Nature Neuroscience

Volume: 27, P: 409-420
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19

The authors demonstrate the presence of SARS-CoV-2 in the nasopharynx and brain, suggesting that the virus is present in the CNS and may enter through the olfactory mucosa, exploiting the close vicinity of olfactory mucosal, endothelial and nervous tissue.

Jenny Meinhardt
Josefine Radke
Frank L. Heppner
Research30 Nov 2020
Nature Neuroscience

Volume: 24, P: 168-175
Distinct tissue niches direct lung immunopathology via CCL18 and CCL21 in severe COVID-19

Infection with SARS-CoV-2 has been linked with substantive inflammation, lung pathology and development of COVID-19. Here the authors spatially associate CCL18 and CCL21 in distinct tissue niches with lung pathology of severe COVID-19.

Ronja Mothes
Anna Pascual-Reguant
Anja E. Hauser
ResearchOpen Access11 Feb 2023
Nature Communications

Volume: 14, P: 1-16
Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells

The improper timing of transforming growth factor-β production is a hallmark of severe COVID-19 that may impede natural killer cell function and early control of infection.

Mario Witkowski
Caroline Tizian
Andreas Diefenbach
Research25 Oct 2021
Nature

Volume: 600, P: 295-301
SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals

Viruses manipulate host cell pathways to support infection. Here the authors show that SARS-CoV-2 infection modulates cellular metabolism and limits autophagy, and identify druggable host pathways for virus inhibition.

Nils C. Gassen
Jan Papies
Marcel A. Müller
ResearchOpen Access21 Jun 2021
Nature Communications

Volume: 12, P: 1-15